Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Koh

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
Response rate is associated with prolonged survival in patients with advanced non-small cell lung cancer treated with gefitinib or erlotinibKazuyuki Tsujino, Tomoya Kawaguchi, Akihito Kubo, et al.
Clinical Lung Cancer|May 21, 2013
Rationale and design of the Japan molecular epidemiology for lung cancer studyTomoya Kawaguchi, Masahiko Ando, Norimasa Ito, et al.
BMC Cancer|July 15, 2022
Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancerYoshiya Matsumoto, Tomoya Kawaguchi, Masaru Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligandsArun K Ghosh, Gary Schiltz, Ramu Sridhar Perali, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavirHironori Hayashi, Nobutoki Takamune, Takashi Nirasawa, et al.
Journal of Virology|September 3, 2010
In vitro selection of highly darunavir-resistant and replication-competent HIV-1 variants by using a mixture of clinical HIV-1 isolates resistant to multiple conventional protease inhibitorsYasuhiro Koh, Masayuki Amano, Tomomi Towata, et al.
Plos One|June 25, 2015
High-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral BloodAtsushi Morimoto, Toshifumi Mogami, Masaru Watanabe, et al.
Journal of Virology|August 5, 2011
Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1Yasuhiro Koh, Manabu Aoki, Matthew L Danish, et al.
Journal of Medicinal Chemistry|May 13, 2005
Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitorsArun K Ghosh, Lisa M Swanson, Hanna Cho, et al.
Anticancer Research|December 31, 2021
High-purity Isolation for Genotyping Rare Cancer Cells from Blood Using a Microfluidic Chip Cell SorterMio Ikeda, Yasuhiro Koh, Jun Oyanagi, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
Response rate is associated with prolonged survival in patients with advanced non-small cell lung cancer treated with gefitinib or erlotinibKazuyuki Tsujino, Tomoya Kawaguchi, Akihito Kubo, et al.
Clinical Lung Cancer|May 21, 2013
Rationale and design of the Japan molecular epidemiology for lung cancer studyTomoya Kawaguchi, Masahiko Ando, Norimasa Ito, et al.
BMC Cancer|July 15, 2022
Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancerYoshiya Matsumoto, Tomoya Kawaguchi, Masaru Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligandsArun K Ghosh, Gary Schiltz, Ramu Sridhar Perali, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavirHironori Hayashi, Nobutoki Takamune, Takashi Nirasawa, et al.
Journal of Virology|September 3, 2010
In vitro selection of highly darunavir-resistant and replication-competent HIV-1 variants by using a mixture of clinical HIV-1 isolates resistant to multiple conventional protease inhibitorsYasuhiro Koh, Masayuki Amano, Tomomi Towata, et al.
Plos One|June 25, 2015
High-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral BloodAtsushi Morimoto, Toshifumi Mogami, Masaru Watanabe, et al.
Journal of Virology|August 5, 2011
Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1Yasuhiro Koh, Manabu Aoki, Matthew L Danish, et al.
Journal of Medicinal Chemistry|May 13, 2005
Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitorsArun K Ghosh, Lisa M Swanson, Hanna Cho, et al.
Anticancer Research|December 31, 2021
High-purity Isolation for Genotyping Rare Cancer Cells from Blood Using a Microfluidic Chip Cell SorterMio Ikeda, Yasuhiro Koh, Jun Oyanagi, et al.
Pageof 15